Tianjin Pharmaceutical Da Ren Tang Group Corp Stock | 600329.SS | CNE000001808 |

Date	Tianjin Pharmaceutical Da Ren Tang Group Corp Price
9/13/2024	26.40 undefined
9/12/2024	26.56 undefined
9/11/2024	27.04 undefined
9/10/2024	27.00 undefined
9/9/2024	27.44 undefined
9/6/2024	27.97 undefined
9/5/2024	28.22 undefined
9/4/2024	28.01 undefined
9/3/2024	28.25 undefined
9/2/2024	28.20 undefined
8/30/2024	28.79 undefined
8/29/2024	28.80 undefined
8/28/2024	27.38 undefined
8/27/2024	27.47 undefined
8/26/2024	27.59 undefined
8/23/2024	27.87 undefined
8/22/2024	28.04 undefined
8/21/2024	28.15 undefined
8/20/2024	28.91 undefined
8/19/2024	29.69 undefined
8/16/2024	31.07 undefined

Date	Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT	Tianjin Pharmaceutical Da Ren Tang Group Corp Net Income
2026e	10.67 B undefined	1.65 B undefined	1.68 B undefined
2025e	9.78 B undefined	1.34 B undefined	1.42 B undefined
2024e	8.97 B undefined	1.08 B undefined	1.18 B undefined
2023	8.22 B undefined	814.79 M undefined	986.71 M undefined
2022	8.25 B undefined	681.08 M undefined	861.79 M undefined
2021	6.91 B undefined	592.64 M undefined	769.14 M undefined
2020	6.6 B undefined	587.5 M undefined	661.7 M undefined
2019	6.99 B undefined	536.8 M undefined	625.6 M undefined
2018	6.36 B undefined	468 M undefined	561.7 M undefined
2017	5.69 B undefined	348.3 M undefined	476.1 M undefined
2016	6.24 B undefined	295.8 M undefined	423.6 M undefined
2015	7.08 B undefined	393.2 M undefined	451.4 M undefined
2014	7.09 B undefined	372.5 M undefined	357.8 M undefined
2013	6.01 B undefined	344.1 M undefined	351.8 M undefined
2012	5.13 B undefined	268 M undefined	441.3 M undefined
2011	4.39 B undefined	271.9 M undefined	247.6 M undefined
2010	3.47 B undefined	236.8 M undefined	293.3 M undefined
2009	2.88 B undefined	168.4 M undefined	257.8 M undefined
2008	2.37 B undefined	92.5 M undefined	176.1 M undefined
2007	2.26 B undefined	-185.7 M undefined	-70 M undefined
2006	2.16 B undefined	-408.2 M undefined	-386.6 M undefined
2005	2.52 B undefined	51.3 M undefined	80.8 M undefined
2004	2.12 B undefined	73.1 M undefined	64 M undefined

	Revenue	EBIT	Net Income
2004	2.12 B CNY	73.1 M CNY	64 M CNY
2005	2.52 B CNY	51.3 M CNY	80.8 M CNY
2006	2.16 B CNY	-408.2 M CNY	-386.6 M CNY
2007	2.26 B CNY	-185.7 M CNY	-70 M CNY
2008	2.37 B CNY	92.5 M CNY	176.1 M CNY
2009	2.88 B CNY	168.4 M CNY	257.8 M CNY
2010	3.47 B CNY	236.8 M CNY	293.3 M CNY
2011	4.39 B CNY	271.9 M CNY	247.6 M CNY
2012	5.13 B CNY	268 M CNY	441.3 M CNY
2013	6.01 B CNY	344.1 M CNY	351.8 M CNY
2014	7.09 B CNY	372.5 M CNY	357.8 M CNY
2015	7.08 B CNY	393.2 M CNY	451.4 M CNY
2016	6.24 B CNY	295.8 M CNY	423.6 M CNY
2017	5.69 B CNY	348.3 M CNY	476.1 M CNY
2018	6.36 B CNY	468 M CNY	561.7 M CNY
2019	6.99 B CNY	536.8 M CNY	625.6 M CNY
2020	6.6 B CNY	587.5 M CNY	661.7 M CNY
2021	6.91 B CNY	592.64 M CNY	769.14 M CNY
2022	8.25 B CNY	681.08 M CNY	861.79 M CNY
2023	8.22 B CNY	814.79 M CNY	986.71 M CNY
2024e	8.97 B CNY	1.08 B CNY	1.18 B CNY
2025e	9.78 B CNY	1.34 B CNY	1.42 B CNY
2026e	10.67 B CNY	1.65 B CNY	1.68 B CNY

Tianjin Pharmaceutical Da Ren Tang Group Corp Gross margin	Tianjin Pharmaceutical Da Ren Tang Group Corp Profit margin	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT margin	Tianjin Pharmaceutical Da Ren Tang Group Corp Profit margin
2026e	43.66 %	15.5 %	15.78 %
2025e	43.66 %	13.66 %	14.54 %
2024e	43.66 %	12.04 %	13.21 %
2023	43.66 %	9.91 %	12 %
2022	39.49 %	8.26 %	10.45 %
2021	39.76 %	8.58 %	11.13 %
2020	39.07 %	8.9 %	10.02 %
2019	41.76 %	7.68 %	8.94 %
2018	41.2 %	7.36 %	8.83 %
2017	38.68 %	6.12 %	8.37 %
2016	32.27 %	4.74 %	6.79 %
2015	29.48 %	5.55 %	6.38 %
2014	30.27 %	5.26 %	5.05 %
2013	31.86 %	5.73 %	5.85 %
2012	34.12 %	5.22 %	8.6 %
2011	34.85 %	6.19 %	5.64 %
2010	37.77 %	6.82 %	8.44 %
2009	37.54 %	5.85 %	8.95 %
2008	36.93 %	3.91 %	7.45 %
2007	34.28 %	-8.22 %	-3.1 %
2006	35.01 %	-18.86 %	-17.86 %
2005	42.58 %	2.04 %	3.21 %
2004	45.13 %	3.45 %	3.02 %

	Gross margin	EBIT margin	Profit margin
2004	45.13 %	3.45 %	3.02 %
2005	42.58 %	2.04 %	3.21 %
2006	35.01 %	-18.86 %	-17.86 %
2007	34.28 %	-8.22 %	-3.1 %
2008	36.93 %	3.91 %	7.45 %
2009	37.54 %	5.85 %	8.95 %
2010	37.77 %	6.82 %	8.44 %
2011	34.85 %	6.19 %	5.64 %
2012	34.12 %	5.22 %	8.6 %
2013	31.86 %	5.73 %	5.85 %
2014	30.27 %	5.26 %	5.05 %
2015	29.48 %	5.55 %	6.38 %
2016	32.27 %	4.74 %	6.79 %
2017	38.68 %	6.12 %	8.37 %
2018	41.2 %	7.36 %	8.83 %
2019	41.76 %	7.68 %	8.94 %
2020	39.07 %	8.9 %	10.02 %
2021	39.76 %	8.58 %	11.13 %
2022	39.49 %	8.26 %	10.45 %
2023	43.66 %	9.91 %	12 %
2024e	43.66 %	12.04 %	13.21 %
2025e	43.66 %	13.66 %	14.54 %
2026e	43.66 %	15.5 %	15.78 %

Date	Tianjin Pharmaceutical Da Ren Tang Group Corp Sales per Share	Tianjin Pharmaceutical Da Ren Tang Group Corp EBIT per share	Tianjin Pharmaceutical Da Ren Tang Group Corp Earnings per Share
2026e	13.87 undefined	0 undefined	2.19 undefined
2025e	12.72 undefined	0 undefined	1.85 undefined
2024e	11.66 undefined	0 undefined	1.54 undefined
2023	10.69 undefined	1.06 undefined	1.28 undefined
2022	10.63 undefined	0.88 undefined	1.11 undefined
2021	8.98 undefined	0.77 undefined	1 undefined
2020	8.59 undefined	0.76 undefined	0.86 undefined
2019	9.1 undefined	0.7 undefined	0.81 undefined
2018	8.26 undefined	0.61 undefined	0.73 undefined
2017	7.4 undefined	0.45 undefined	0.62 undefined
2016	8.12 undefined	0.38 undefined	0.55 undefined
2015	9.21 undefined	0.51 undefined	0.59 undefined
2014	9.59 undefined	0.5 undefined	0.48 undefined
2013	8.13 undefined	0.47 undefined	0.48 undefined
2012	6.94 undefined	0.36 undefined	0.6 undefined
2011	5.94 undefined	0.37 undefined	0.33 undefined
2010	4.7 undefined	0.32 undefined	0.4 undefined
2009	3.9 undefined	0.23 undefined	0.35 undefined
2008	3.2 undefined	0.13 undefined	0.24 undefined
2007	3.05 undefined	-0.25 undefined	-0.09 undefined
2006	2.93 undefined	-0.55 undefined	-0.52 undefined
2005	3.4 undefined	0.07 undefined	0.11 undefined
2004	2.86 undefined	0.1 undefined	0.09 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	2.86 CNY	0.1 CNY	0.09 CNY
2005	3.4 CNY	0.07 CNY	0.11 CNY
2006	2.93 CNY	-0.55 CNY	-0.52 CNY
2007	3.05 CNY	-0.25 CNY	-0.09 CNY
2008	3.2 CNY	0.13 CNY	0.24 CNY
2009	3.9 CNY	0.23 CNY	0.35 CNY
2010	4.7 CNY	0.32 CNY	0.4 CNY
2011	5.94 CNY	0.37 CNY	0.33 CNY
2012	6.94 CNY	0.36 CNY	0.6 CNY
2013	8.13 CNY	0.47 CNY	0.48 CNY
2014	9.59 CNY	0.5 CNY	0.48 CNY
2015	9.21 CNY	0.51 CNY	0.59 CNY
2016	8.12 CNY	0.38 CNY	0.55 CNY
2017	7.4 CNY	0.45 CNY	0.62 CNY
2018	8.26 CNY	0.61 CNY	0.73 CNY
2019	9.1 CNY	0.7 CNY	0.81 CNY
2020	8.59 CNY	0.76 CNY	0.86 CNY
2021	8.98 CNY	0.77 CNY	1 CNY
2022	10.63 CNY	0.88 CNY	1.11 CNY
2023	10.69 CNY	1.06 CNY	1.28 CNY
2024e	11.66 CNY	0 CNY	1.54 CNY
2025e	12.72 CNY	0 CNY	1.85 CNY
2026e	13.87 CNY	0 CNY	2.19 CNY

	Number of stocks
2004	739.3 M Aktien
2005	739.3 M Aktien
2006	739.3 M Aktien
2007	739.3 M Aktien
2008	739.3 M Aktien
2009	739.3 M Aktien
2010	739.3 M Aktien
2011	739.3 M Aktien
2012	739.3 M Aktien
2013	739.3 M Aktien
2014	739.3 M Aktien
2015	768.9 M Aktien
2016	768.9 M Aktien
2017	768.9 M Aktien
2018	769.4 M Aktien
2019	768.9 M Aktien
2020	768.9 M Aktien
2021	769.14 M Aktien
2022	776.39 M Aktien
2023	768.87 M Aktien
2024e	768.87 M Aktien
2025e	768.87 M Aktien
2026e	768.87 M Aktien

Date	Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend
2026e	1.21 undefined
2025e	1.21 undefined
2024e	1.21 undefined
2023	1.12 undefined
2022	0.5 undefined
2021	0.3 undefined
2020	0.3 undefined
2019	0.22 undefined
2018	0.2 undefined
2017	0.15 undefined
2016	0.25 undefined
2015	0.15 undefined
2014	0.05 undefined
2013	0.1 undefined
2012	0.2 undefined
2011	0.2 undefined
2006	0.08 undefined
2005	0.08 undefined
2004	0.08 undefined

	Dividend	Dividend (Estimate)
2004	0.08 CNY	0 CNY
2005	0.08 CNY	0 CNY
2006	0.08 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0.2 CNY	0 CNY
2012	0.2 CNY	0 CNY
2013	0.1 CNY	0 CNY
2014	0.05 CNY	0 CNY
2015	0.15 CNY	0 CNY
2016	0.25 CNY	0 CNY
2017	0.15 CNY	0 CNY
2018	0.2 CNY	0 CNY
2019	0.22 CNY	0 CNY
2020	0.3 CNY	0 CNY
2021	0.3 CNY	0 CNY
2022	0.5 CNY	0 CNY
2023	1.12 CNY	0 CNY
2024e	0 CNY	1.21 CNY
2025e	0 CNY	1.21 CNY
2026e	0 CNY	1.21 CNY

Date	Tianjin Pharmaceutical Da Ren Tang Group Corp Payout ratio
2026e	37.84 %
2025e	39.64 %
2024e	37.23 %
2023	36.64 %
2022	45.05 %
2021	30 %
2020	34.88 %
2019	27.16 %
2018	27.4 %
2017	24.19 %
2016	45.45 %
2015	25.42 %
2014	10.42 %
2013	20.83 %
2012	33.33 %
2011	60.61 %
2010	36.64 %
2009	36.64 %
2008	36.64 %
2007	36.64 %
2006	-14.42 %
2005	68.18 %
2004	83.33 %

	Payout ratio
2004	83.33 %
2005	68.18 %
2006	-14.42 %
2007	36.64 %
2008	36.64 %
2009	36.64 %
2010	36.64 %
2011	60.61 %
2012	33.33 %
2013	20.83 %
2014	10.42 %
2015	25.42 %
2016	45.45 %
2017	24.19 %
2018	27.4 %
2019	27.16 %
2020	34.88 %
2021	30 %
2022	45.05 %
2023	36.64 %
2024e	37.23 %
2025e	39.64 %
2026e	37.84 %

Date	EPS Estimate	EPS Actual	Quarterly report
12/31/2014	0.22	0.13 (-41.49 %)	2014 Q4
9/30/2014	0.18	0.08 (-56 %)	2014 Q3
6/30/2014	0.15	0.13 (-14.19 %)	2014 Q2
12/31/2013	0.21	0.16 (-24.56 %)	2013 Q4
9/30/2013	0.14	0.06 (-57.57 %)	2013 Q3
6/30/2013	0.13	0.1 (-20.82 %)	2013 Q2

%	Name	Stocks	Change	Date
42.38094 %	Tianjin Pharmaceutical Holdings Ltd.	325,855,528	0	12/31/2023
1.09148 %	Fullgoal Fund Management Co., Ltd.	8,392,119	-340,800	12/31/2023
0.69569 %	Zhong Ou Asset Management Co., Ltd.	5,348,982	-8,489,300	12/31/2023
0.61278 %	GF Fund Management Co., Ltd.	4,711,501	-1,989,900	12/31/2023
0.57462 %	Chen (Shihui)	4,418,118	4,418,118	12/31/2023
0.53637 %	China Universal Asset Management Co., Ltd.	4,124,015	-422,094	12/31/2023
0.31394 %	Hotland Innovation Asset Management Co., Ltd.	2,413,803	-230,080	12/31/2023
0.29290 %	E Fund Management Co. Ltd.	2,252,050	-2,748,720	6/30/2023
0.28984 %	China Southern Asset Management Co. Ltd.	2,228,492	117,800	12/31/2023
0.27411 %	ICBC Credit Suisse Asset Management Co. Ltd.	2,107,589	-243,100	12/31/2023
0.23479 %	Cinda Fund Management Co., Ltd.	1,805,256	-2,020,600	12/31/2023
0.22398 %	China Asset Management Co., Ltd.	1,722,109	53,900	12/31/2023
0.20671 %	Bosera Asset Management Co., Ltd.	1,589,300	-30,200	12/31/2023
0.19649 %	Penghua Fund Management Co., Ltd.	1,510,738	310,800	6/30/2023
0.18658 %	ZhongRong Fund Mgmt Co., Ltd	1,434,538	-638,862	6/30/2023
0.17055 %	The Vanguard Group, Inc.	1,311,297	0	3/31/2024
0.16313 %	JPMorgan Asset Management (China) Company Limited.	1,254,249	1,214,649	6/30/2023
0.15007 %	China Merchants Fund Management Co. Ltd.	1,153,883	-160,300	12/31/2023
0.13528 %	Western Leadbank Fund Management Co., Ltd.	1,040,100	1,040,100	6/30/2023
0.11876 %	CCB Principal Asset Management Co., Ltd.	913,135	103,700	12/31/2023
0.10579 %	AXA-SPDB Investment Managers Co., Ltd.	813,400	695,400	12/31/2023
0.10447 %	Harvest Fund Management Co., Ltd.	803,209	-741,615	6/30/2023
0.09005 %	Guotai Junan Securities Assets Management Co., Ltd.	692,400	692,400	6/30/2023
0.08930 %	Broad Asset Management Co., Ltd	686,600	686,600	6/30/2023
0.08172 %	Great Wall Fund Management Co., Ltd.	628,300	-21,700	12/31/2023
0.07534 %	Tianhong Asset Management Co., Ltd.	579,300	14,300	12/31/2023
0.07292 %	CITIC Prudential Fund Management Co., Ltd.	560,672	500,000	12/31/2023
0.07129 %	Zhong Hai Fund Management Co., Ltd.	548,127	548,127	12/31/2023
0.06478 %	Changsheng Fund Management Co., Ltd.	498,100	-25,400	12/31/2023
0.06246 %	Morgan Stanley Investment Management (China) Company Limited.	480,200	30,300	6/30/2023
0.05992 %	Founder Fubon Fund Management Co., Ltd.	460,677	0	12/31/2023
0.05958 %	Norges Bank Investment Management (NBIM)	458,108	458,108	12/31/2023
0.05049 %	First-Trust Fund Management Co., Ltd.	388,188	-157,228	6/30/2023
0.04542 %	Hongde Fund Management Co., Ltd.	349,200	-696,900	6/30/2023
0.03873 %	Bank of Communications Schroder Fund Management Co., Ltd.	297,773	-5,088,456	6/30/2023
0.03552 %	Baoying Fund Management Co., Ltd.	273,100	-499,300	12/31/2023
0.03384 %	Dacheng Fund Management Co., Ltd.	260,201	256,600	6/30/2023
0.03207 %	Value Partners Ltd.	246,572	-41,400	12/31/2023
0.02861 %	Maxwealth Fund Management Co., Ltd.	220,000	218,100	6/30/2023
0.02757 %	Chang Xin Asset Management Co., Ltd.	212,000	-269,200	12/31/2023
0.02692 %	PengYang Asset Management Co., Ltd	207,000	207,000	6/30/2023
0.02601 %	Huashang Fund Management Co., Ltd.	200,000	200,000	6/30/2023
0.02580 %	Dimensional Fund Advisors, L.P.	198,372	-200	2/29/2024
0.02576 %	Yinhua Fund Management Co., Ltd.	198,031	125,400	12/31/2023
0.02562 %	Everbright PGIM Fund Management Co., Ltd.	197,000	-179,100	6/30/2023
0.02220 %	CICC Fund Management Co Ltd.	170,700	-6,500	12/31/2023
0.02175 %	INVESCO Great Wall Fund Management Co. Ltd.	167,255	-3,200	12/31/2023
0.02174 %	Wanjia Asset Management Co., Ltd.	167,159	-2,781,983	6/30/2023
0.01857 %	BOC International (China) Ltd.	142,800	200	12/31/2023
0.01509 %	Hwabao WP Fund Management Co., Ltd.	116,000	90,000	12/31/2023
0.01467 %	Huatai-PineBridge Fund Management Co., Ltd.	112,780	-214,603	6/30/2023
0.01349 %	TongTai Asset Management Co., Ltd.	103,700	103,700	6/30/2023
0.01275 %	Focusbridge Investments Limited	98,000	98,000	6/30/2023
0.01243 %	Orient Securities Asset Management Company Limited	95,600	95,600	6/30/2023
0.01242 %	Handelsbanken Kapitalförvaltning AB	95,500	0	3/31/2024
0.01207 %	UBS SDIC Fund Management Co., Ltd.	92,800	15,100	12/31/2023
0.01141 %	BOSC Asset Management Co., Ltd.	87,700	-33,600	12/31/2023
0.01007 %	Ping An Fund Management Company Limited	77,400	-6,200	12/31/2023
0.00886 %	ABC-CA Fund Management Co., Ltd.	68,100	-2,897,300	12/31/2023
0.00627 %	Xinghua Fund Management Co., Ltd.	48,200	48,200	6/30/2023
0.00614 %	Soochow Asset Management Co., Ltd.	47,200	-34,900	12/31/2023
0.00541 %	China Fund Management Co., Ltd.	41,600	-28,600	12/31/2023
0.00503 %	Guotai Asset Management Co., Ltd.	38,700	-445,509	6/30/2023
0.00497 %	BlackRock Investment Management (UK) Ltd.	38,200	0	2/29/2024
0.00433 %	SWS MU Fund Management Co., Ltd.	33,300	33,300	6/30/2023
0.00417 %	JX Asset Management Co., Ltd.	32,078	-84,800	6/30/2023
0.00415 %	Topsperity Fund Management Co., Ltd.	31,900	22,300	12/31/2023
0.00365 %	Taikang Asset Management Co., Ltd.	28,100	25,000	12/31/2023
0.00359 %	CITIC Securities Co., Ltd. (Asset Management)	27,600	27,600	6/30/2023
0.00349 %	Donghai Funds Management Co., Ltd.	26,800	26,800	6/30/2023
0.00334 %	Manulife Fund Management Co., Ltd.	25,700	1,000	12/31/2023
0.00310 %	Sealand Securities Co., Ltd.	23,849	14,349	6/30/2023
0.00310 %	Zhou (Hong)	23,800	-46,200	12/31/2023
0.00310 %	Wang (Xin)	23,800	-46,200	12/31/2023
0.00310 %	Niu (Sheng Fang)	23,800	-46,200	12/31/2023
0.00269 %	Horizon Asset Management Co., Ltd.	20,700	-4,100	6/30/2023
0.00243 %	AVIC Fund Management Co., Ltd.	18,700	12,600	6/30/2023
0.00235 %	Caitong Fund Management Co., Ltd.	18,100	-31,200	12/31/2023
0.00224 %	China Life AMP Asset Management Co., Ltd	17,200	-300	12/31/2023
0.00221 %	China Everbright Assets Management, Ltd.	17,000	17,000	6/30/2023
0.00220 %	HuaAn Fund Management Co., Ltd.	16,900	-1,328,600	6/30/2023
0.00195 %	Goldstate Capital Fund Management Co., Ltd.	15,000	15,000	6/30/2023
0.00189 %	CPIC Fund Management Co., Ltd.	14,500	14,500	6/30/2023
0.00181 %	DBX Advisors LLC.	13,900	13,900	2/29/2024
0.00174 %	Nykredit Bank AS	13,400	0	2/29/2024
0.00169 %	Dimensional Fund Advisors, Ltd.	13,000	-6,600	2/29/2024
0.00159 %	Minsheng Royal Fund Management Company Ltd.	12,200	4,800	6/30/2023
0.00153 %	Neuberger Berman Fund Management (China) Co., Ltd.	11,739	11,739	6/30/2023
0.00137 %	Truvalue Asset Management Co., Ltd.	10,500	-1,186,838	6/30/2023
0.00133 %	Jiao (Yan)	10,200	-19,800	12/31/2023
0.00131 %	Shanghai Haitong Securities Asset Management Ltd.	10,100	-3,800	12/31/2023
0.00124 %	Tibet Eastmoney Fund Management Co., Ltd.	9,500	-100	6/30/2023
0.00121 %	Xingyin Fund Management Co., Ltd.	9,300	9,300	6/30/2023
0.00117 %	Orient Fund Management Co. Ltd.	9,000	-70,000	6/30/2023
0.00093 %	Harvest Global Investments Limited	7,162	0	2/29/2024
0.00091 %	Jyah Asset Management.Co.,LTD	7,000	5,500	6/30/2023
0.00085 %	Golden Trust Sinopac Fund Management Co., Ltd.	6,500	6,500	6/30/2023
0.00079 %	Essence Fund Management Co., Ltd.	6,100	-9,400	12/31/2023
0.00075 %	Everbright Securities Asset Management Co., Ltd.	5,800	-5,900	12/31/2023
0.00064 %	Northeast Ronghui Securities Asset Management Co., Ltd.	4,900	4,900	6/30/2023

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Citigroup	SupplierCustomer	0,69	-0,04	0,80	0,66	0,43	0,57
GlaxoSmithKline	SupplierCustomer	0,36	-0,43	-0,80	-0,59	-0,42	0,31
Standard Chartered	SupplierCustomer	0,33	0,71	-0,68	-0,32	-0,34	0,26
Tianjin Lisheng Pharm A	SupplierCustomer	0,12	0,91	0,83	0,28	0,17	-0,40
Tianjin Development Hldgs	SupplierCustomer	0,05	-0,58	0,72	0,34	0,18	0,54
DBS Group Holdings	SupplierCustomer	-0,53	-0,72	0,53	0,47	0,02	0,75
ABN AMRO DR	SupplierCustomer	-0,70	-0,75	-0,21	0,60	0,30	0,78

What values and corporate philosophy does Tianjin Pharmaceutical Da Ren Tang Group Corp represent?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd represents values of innovation, integrity, and quality in the pharmaceutical industry. With a strong corporate philosophy focused on delivering cutting-edge healthcare solutions, the company strives to provide safe and effective pharmaceutical products to improve people's well-being. Tianjin Zhongxin Pharmaceutical Group Corp Ltd's commitment to research and development, along with its dedication to meeting international standards, has positioned the company as a leader in the global pharmaceutical market. Through its emphasis on quality control, continuous improvement, and customer satisfaction, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the delivery of reliable and trustworthy healthcare solutions.

In which countries and regions is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily present?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is primarily present in China.

What significant milestones has the company Tianjin Pharmaceutical Da Ren Tang Group Corp achieved?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd has achieved several significant milestones. It has successfully expanded its product portfolio, notably in the areas of cardiovascular, respiratory, and anti-infective medicines. The company has also secured numerous international certifications, including Good Manufacturing Practice (GMP) certification, ensuring the highest quality standards. Tianjin Zhongxin Pharmaceutical Group Corp Ltd has made remarkable strides in research and development as well, with several innovative drugs being registered and commercialized. Furthermore, the company has established a robust global presence by entering into strategic partnerships and expanding its market reach. These achievements consolidate Tianjin Zhongxin Pharmaceutical Group Corp Ltd's position as a leading player in the pharmaceutical industry.

What is the history and background of the company Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd, a leading pharmaceutical company, has a rich history and background. Established in [year], the company has been dedicated to providing high-quality healthcare products and services to global markets. With a focus on research and development, manufacturing, and marketing, Tianjin Zhongxin has emerged as a trusted name in the pharmaceutical industry. Its commitment to innovation, quality, and customer satisfaction has enabled it to expand its presence both domestically and internationally. Being one of the prominent players in the pharmaceutical market, Tianjin Zhongxin Pharmaceutical Group Corp Ltd continuously strives for excellence through its diverse product portfolio and relentless pursuit of breakthrough solutions in healthcare.

Who are the main competitors of Tianjin Pharmaceutical Da Ren Tang Group Corp in the market?

The main competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd in the market include other leading pharmaceutical companies such as Shanghai Pharmaceuticals Holding Co., Ltd., Sinopharm Group Co., Ltd., Fosun Pharma, and Jiangsu Hengrui Medicine Co., Ltd.

In which industries is Tianjin Pharmaceutical Da Ren Tang Group Corp primarily active?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd primarily operates in the pharmaceutical industry.

What is the business model of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd focuses on the development, production, and sales of pharmaceutical products. As one of the leading pharmaceutical companies in China, Tianjin Zhongxin Pharmaceutical Group Corp Ltd aims to provide high-quality and affordable medications to improve the health and well-being of individuals. With a diverse product portfolio ranging from traditional Chinese medicine to modern pharmaceuticals, the company emphasizes research and innovation to meet the growing healthcare needs of its customers. By adhering to strict quality standards and maintaining a strong distribution network, Tianjin Zhongxin Pharmaceutical Group Corp Ltd ensures the availability and accessibility of its products nationwide.

What is the P/E ratio of Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

The Tianjin Pharmaceutical Da Ren Tang Group Corp P/E ratio is 17.13.

What is the P/S ratio of Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

The Tianjin Pharmaceutical Da Ren Tang Group Corp P/S ratio is 2.26.

What is the AlleAktien quality score of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The AlleAktien quality score for Tianjin Pharmaceutical Da Ren Tang Group Corp is 7/10.

What is the revenue of Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

The expected Tianjin Pharmaceutical Da Ren Tang Group Corp revenue is 8.97 B CNY.

How high is the profit of Tianjin Pharmaceutical Da Ren Tang Group Corp 2024?

The expected Tianjin Pharmaceutical Da Ren Tang Group Corp profit is 1.18 B CNY.

What is the business model of Tianjin Pharmaceutical Da Ren Tang Group Corp

Tianjin Zhongxin Pharmaceutical Group Corp Ltd is a Chinese company specialized in the production and sale of pharmaceutical products, health and dietary supplements, and medical devices. Its business model is based on a comprehensive range of products and services that allow it to meet the needs of customers in different markets. The company is divided into several divisions, including the pharmaceutical products division, the dietary supplements division, and the medical devices division. Each of these divisions offers unique products and services tailored to specific needs and requirements. In the field of pharmaceutical products, Tianjin Zhongxin Pharmaceutical Group Corp Ltd manufactures a variety of drugs used to treat various diseases and conditions. This includes antibiotics, anti-inflammatory drugs, cancer medications, as well as treatments for cardiovascular diseases and diabetes. The company also has a research and development department that continuously works on the development of new drugs. The dietary supplements division offers a wide range of products aimed at improving health and well-being. These include vitamins, minerals, enzymes, and herbal extracts. The company adheres to strict standards in the production of its products and uses only high-quality and natural ingredients. The medical devices division of Tianjin Zhongxin Pharmaceutical Group Corp Ltd specializes in the production of medical devices such as blood glucose monitors and blood pressure monitors. These devices are of high quality and comply with all applicable standards and regulations. The business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd also includes collaborations with other companies and organizations around the world. The company has partnerships with a variety of domestic and international companies to expand its product range and strengthen its global presence. Overall, the business model of Tianjin Zhongxin Pharmaceutical Group Corp Ltd is focused on the development, production, and sale of high-quality pharmaceutical products, dietary supplements, and medical devices. Its divisions offer a wide range of products and services tailored to the needs of customers in different markets. Through its global presence and collaborations with other companies and organizations worldwide, the company ensures continuous expansion and future success.

What is the Tianjin Pharmaceutical Da Ren Tang Group Corp dividend?

Tianjin Pharmaceutical Da Ren Tang Group Corp pays a dividend of 0.5 CNY distributed over payouts per year.

How often does Tianjin Pharmaceutical Da Ren Tang Group Corp pay dividends?

The dividend cannot currently be calculated for Tianjin Pharmaceutical Da Ren Tang Group Corp or the company does not pay out a dividend.

What is the Tianjin Pharmaceutical Da Ren Tang Group Corp ISIN?

The ISIN of Tianjin Pharmaceutical Da Ren Tang Group Corp is CNE000001808.

What is the Tianjin Pharmaceutical Da Ren Tang Group Corp ticker?

The ticker of Tianjin Pharmaceutical Da Ren Tang Group Corp is 600329.SS.

How much dividend does Tianjin Pharmaceutical Da Ren Tang Group Corp pay?

Over the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corp paid a dividend of 1.12 CNY . This corresponds to a dividend yield of about 4.24 %. For the coming 12 months, Tianjin Pharmaceutical Da Ren Tang Group Corp is expected to pay a dividend of 1.21 CNY.

What is the dividend yield of Tianjin Pharmaceutical Da Ren Tang Group Corp?

The current dividend yield of Tianjin Pharmaceutical Da Ren Tang Group Corp is 4.24 %.

When does Tianjin Pharmaceutical Da Ren Tang Group Corp pay dividends?

Tianjin Pharmaceutical Da Ren Tang Group Corp pays a quarterly dividend. This is distributed in the months of July, July, July, August.

How secure is the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp?

Tianjin Pharmaceutical Da Ren Tang Group Corp paid dividends every year for the past 16 years.

What is the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp?

For the upcoming 12 months, dividends amounting to 1.21 CNY are expected. This corresponds to a dividend yield of 4.58 %.

In which sector is Tianjin Pharmaceutical Da Ren Tang Group Corp located?

Tianjin Pharmaceutical Da Ren Tang Group Corp is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tianjin Pharmaceutical Da Ren Tang Group Corp kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp from 7/12/2024 amounting to 1.28 CNY, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Tianjin Pharmaceutical Da Ren Tang Group Corp pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Tianjin Pharmaceutical Da Ren Tang Group Corp in the year 2023?

In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corp distributed 0.5 CNY as dividends.

In which currency does Tianjin Pharmaceutical Da Ren Tang Group Corp pay out the dividend?

The dividends of Tianjin Pharmaceutical Da Ren Tang Group Corp are distributed in CNY.

1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.27	0.33	0.28	0.45	0.45	0.44	0.28	0.41	0.33	0.36	0.36	0.36	0.37	0.41	0.42	0.6	0.63	1.11	1.16	0.98	1.51	1.52	1.99	2.77	2.75	2.02
0.19	0.2	0.33	0.33	0.36	0.39	0.41	0.39	0.3	0.27	0.32	0.44	0.47	0.64	0.82	1	1.33	1.28	1.19	1.25	1.32	1.37	1.51	1.54	2.15	2.17
25.2	27.6	68.5	158.2	132.6	156.6	209.6	234.9	165	243.9	197.9	249.2	224.6	249.2	337	479.2	414.2	460	302.2	291.7	408.6	435.6	494.6	546.73	675.11	549.84
0.06	0.09	0.53	0.49	0.5	0.57	0.59	0.56	0.49	0.4	0.44	0.52	0.6	0.73	0.77	0.82	0.86	0.97	0.93	1.1	1.33	1.59	1.49	1.53	1.43	1.57
8.8	1.4	8.9	3.9	29.3	43.7	90.2	65.6	56.7	54	63.3	70.4	97.6	135.8	146.3	290.9	151	175.8	364.4	339.8	214.8	208.7	121.1	48.54	242.52	244.93
0.56	0.66	1.22	1.43	1.47	1.61	1.58	1.66	1.34	1.33	1.39	1.64	1.77	2.16	2.5	3.19	3.38	4	3.95	3.96	4.78	5.13	5.6	6.42	7.25	6.55
0.33	0.42	0.68	0.74	0.86	1.38	1.53	1.62	1.34	1.27	1.23	1.14	1.14	1.11	0.91	0.89	0.87	0.92	1	1.09	1.22	1.41	1.48	1.52	1.5	1.49
0.27	0.25	0.3	0.27	0.41	0.51	0.53	0.52	0.66	0.71	0.6	0.63	0.65	0.59	0.74	0.89	0.89	0.86	1.2	1.28	0.8	0.93	0.83	0.76	0.82	1.52
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	40.73	60.54	0
14.2	23.8	234.5	236.2	231	251.3	249.2	243.4	213.6	176.1	197.7	207.9	209.3	203.7	178.9	198.6	193.1	188	180.7	179.3	174.9	175.6	204	202.91	292.13	330.83
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	84.69	65.91
97.8	102.4	78.3	32.5	31.1	40.7	33.1	14.3	3.2	0	25.4	52.3	66.2	88.6	96.2	102.7	103.2	95.5	102.5	115.2	142.2	190.6	172.8	162.2	214.89	271.22
0.72	0.79	1.29	1.28	1.53	2.19	2.34	2.39	2.22	2.15	2.06	2.03	2.07	1.99	1.92	2.07	2.06	2.07	2.49	2.66	2.33	2.71	2.68	2.68	2.97	3.68
1.28	1.45	2.51	2.7	3.01	3.8	3.91	4.06	3.55	3.48	3.45	3.67	3.84	4.14	4.42	5.26	5.44	6.07	6.44	6.62	7.11	7.84	8.28	9.11	10.22	10.23

329.7	329.7	329.7	369.7	369.7	369.7	369.7	369.7	369.7	369.7	369.7	369.7	739.3	739.3	739.3	739.3	739.3	768.9	768.9	768.9	768.9	772.8	773.6	773.44	773.44	770.16
0.53	0.53	0.53	0.89	0.93	0.93	0.93	0.93	1.01	1.03	0.98	0.99	0.61	0.59	0.56	0.52	0.52	1.31	1.38	1.32	1.32	1.35	1.37	1.37	1.05	0.98
0.15	0.2	0.19	0.18	0.27	0.3	0.31	0.33	-0.23	-0.3	-0.1	0.16	0.45	0.55	0.84	1.12	1.44	1.78	1.98	2.34	2.75	3.21	3.68	4.22	4.7	4.83
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35.8	61.3	64.7	52.6	48.2	81.9	86.2	23.2	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.62	29.53	34.34
1.02	1.06	1.05	1.44	1.56	1.6	1.6	1.63	1.15	1.1	1.25	1.52	1.8	1.88	2.14	2.42	2.76	3.92	4.18	4.48	4.93	5.42	5.84	6.4	6.55	6.61
21.6	36.4	190.1	184	242.1	254.8	259	226.2	301.5	289.8	296.4	448.8	423.3	474.4	519.9	553.6	659.1	645.1	546.4	538.1	588.2	660.9	666.3	598.61	724.33	615.38
12.6	21.6	31.1	14	17.7	25.1	15	10.6	25.1	135.8	88	120.1	123	118.1	117.5	92.5	106.2	121.8	120.5	125.4	164.9	191.3	160.9	162.85	304.99	336.66
0.1	0.13	0.36	0.33	0.2	0.2	0.22	0.22	0.21	0.4	0.47	0.25	0.3	0.36	0.48	0.5	0.55	0.47	0.43	0.82	0.9	1.3	1.1	0.91	1.39	1.57
0.09	0.09	0.4	0.39	0.62	1.2	1.38	1.25	1.02	0.73	0.95	0.89	0.68	0.78	0.97	1.41	1.04	0.61	0.87	0.38	0.26	0.01	0.24	0.73	0.91	0.71
0	5	91.5	74.6	71.6	55.3	50.9	9	0	420	120	0	6	142.8	0	0	0	0	0	0	0.9	1	1	31.6	4.1	3.56
0.22	0.29	1.07	0.99	1.15	1.74	1.92	1.72	1.56	1.98	1.92	1.71	1.53	1.87	2.08	2.55	2.36	1.84	1.97	1.86	1.92	2.16	2.16	2.43	3.33	3.23
0	13.5	297.6	171.6	100	177.7	102.7	379	540	120	0	100	144	1.2	0	0	0	0	0	0	3.7	32.7	31.7	1.57	152.17	243.78
0	0	0	0	0	0	0	0	0	22.2	6.9	9.7	6.2	3.7	4.1	4.3	8.5	9.3	7.3	7	5.9	8.9	3.8	4.21	8.82	7.33
0.6	4.5	4.5	4.5	10.5	38.2	10.3	11.1	73.3	18.8	28.7	60.2	66.7	64.1	52.7	130.5	120.1	114.1	122.6	127.9	130.9	121.1	134.1	113.57	110.6	100.83
0.6	18	302.1	176.1	110.5	215.9	113	390.1	613.3	161	35.6	169.9	216.9	69	56.8	134.8	128.6	123.4	129.9	134.9	140.5	162.7	169.6	119.35	271.59	351.94
0.22	0.31	1.38	1.17	1.26	1.96	2.04	2.11	2.17	2.15	1.96	1.88	1.75	1.94	2.14	2.69	2.49	1.96	2.1	2	2.06	2.32	2.33	2.55	3.61	3.58
1.24	1.37	2.43	2.61	2.83	3.55	3.64	3.74	3.32	3.24	3.21	3.4	3.55	3.82	4.28	5.1	5.25	5.89	6.28	6.47	6.98	7.74	8.18	8.95	10.16	10.19

1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	769	861
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123	114
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	-56
-84	-198	-353	-350	-462	-536	-667	-682	-493	-471	-629	-611	-737	-884	-1,370	-1,547	-1,679	-1,664	-1,816	-2,084	-2,305	-2,068	-2,316	-2,255
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-186	-191
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-59	-93	-146	-162	-180	-203	-178	-198	-197	-260	-254	-328	-374	-424	-495	-511	-505	-487	-514	-554	-598	-523	-496	-526
69	-14	157	187	76	10	261	-28	20	113	83	139	173	20	213	286	360	417	-4	350	495	671	852	677
-54	-79	-134	-180	-589	-252	-149	-63	-53	-38	-86	-68	-43	-41	-72	-70	-92	-118	-114	-175	-205	-189	-156	-107
74	22	-67	-114	-654	-109	-61	120	253	97	22	11	33	22	-166	102	-428	86	197	382	-100	73	-311	-12
128	101	66	65	-65	143	88	184	307	135	108	80	76	63	-93	172	-335	204	311	557	104	262	-154	95
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-22	-1	-244	51	564	114	64	-51	-145	-162	-49	-80	5	63	185	-273	-367	-19	-42	-10	-222	0	0	179
14	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-83	-85	54	-22	505	-4	-67	-187	-234	-246	-86	-120	-197	-75	266	-491	273	-339	-161	-252	-370	-237	-244	-236
-75	-83	369	22	28	9	5	0	0	0	19	4	1	0	239	-99	784	-114	8	-77	25	-4	-12	-29
0	0	-69	-96	-87	-128	-136	-136	-89	-84	-56	-45	-204	-138	-157	-118	-143	-205	-127	-164	-173	-232	-232	-387
0.27	0.2	0.8	0.75	0.65	0.65	1.24	0.76	0.75	0.81	0.99	1.11	1.3	1.3	2.39	2.24	2.75	2.73	2.36	3.47	3.42	3.77	3.96	3.89
14.8	-93.9	23.7	7.2	-512.6	-241.8	112.1	-91.8	-33.6	75.4	-3.3	70.2	130.9	-20.4	141	216.7	268	299.6	-118.4	174.3	289.9	482.2	695.45	569.34
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Scope 1 - Direct Emissions	5,901.71
Scope 2 - Indirect emissions from purchased energy	31,489.237
Scope 3 - Indirect emissions within the value chain	—
Total CO₂ emissions	37,390.947
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	❌
Environmentally friendly packaging	❌
Hazardous substances	❌
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Percentage of female employees	32.236
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	❌
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	❌
Antitrust law	❌

Tianjin Pharmaceutical Da Ren Tang Group Corp Ticker	Tianjin Pharmaceutical Da Ren Tang Group Corp FIGI
600329:CH	BBG000CWRRB4
600329:CG	BBG000CWRRX0
600329:C1	BBG00709HMS7

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

Ticker600329.SS

ISINCNE000001808

Tianjin Pharmaceutical Da Ren Tang Group Corp stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Tianjin Pharmaceutical Da Ren Tang Group Corp Stock Price History

Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue, EBIT, Net Income CNE000001808 ·

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue, EBIT and net profit per share

Tianjin Pharmaceutical Da Ren Tang Group Corp Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Tianjin Pharmaceutical Da Ren Tang Group Corp stock margins CNE000001808 ·

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Tianjin Pharmaceutical Da Ren Tang Group Corp Margin History

Tianjin Pharmaceutical Da Ren Tang Group Corp Stock Sales Revenue, EBIT, Earnings per Share CNE000001808 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Tianjin Pharmaceutical Da Ren Tang Group Corp Revenue, EBIT and net profit per share

Tianjin Pharmaceutical Da Ren Tang Group Corp business model

Tianjin Pharmaceutical Da Ren Tang Group Corp SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Tianjin Pharmaceutical Da Ren Tang Group Corp Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Tianjin Pharmaceutical Da Ren Tang Group Corp historical P/E ratio, EBIT, and P/S ratio.

Tianjin Pharmaceutical Da Ren Tang Group Corp shares outstanding CNE000001808 ·

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Tianjin Pharmaceutical Da Ren Tang Group Corp Stock splits

Tianjin Pharmaceutical Da Ren Tang Group Corp dividend history and estimates CNE000001808 ·

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Tianjin Pharmaceutical Da Ren Tang Group Corp Dividend History

Tianjin Pharmaceutical Da Ren Tang Group Corp dividend payout ratio CNE000001808 ·

Payout ratio

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
600329.SS

ISIN
CNE000001808